GRANULES INDIA
Back to Income Statement
|
GRANULES INDIA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹502 Cr | ₹405 Cr | ₹517 Cr | ₹413 Cr | ₹5,495 Cr |
What is the latest Consolidated Net Profit of GRANULES INDIA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹502 Cr |
| Mar2025 | ₹405 Cr |
| Mar2024 | ₹517 Cr |
| Mar2023 | ₹413 Cr |
| Mar2022 | ₹5,495 Cr |
How is Consolidated Net Profit of GRANULES INDIA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹502 Cr | 23.74 | |
| Mar2025 | ₹405 Cr | -21.54 | |
| Mar2024 | ₹517 Cr | 25.16 | |
| Mar2023 | ₹413 Cr | -92.49 | |
| Mar2022 | ₹5,495 Cr | - | |
Compare Consolidated Net Profit of peers of GRANULES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GRANULES INDIA | ₹21,475.6 Cr | 3.5% | -0.7% | 66.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,826.0 Cr | -1.6% | -2.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,019.0 Cr | 1.5% | 12.8% | 48.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,875.0 Cr | -0.9% | -0.8% | 35.3% | Stock Analytics | |
| CIPLA | ₹112,773.0 Cr | -1.6% | -5.2% | -11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,570.9 Cr | -2.2% | -2.3% | -8.2% | Stock Analytics | |
GRANULES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | 3.5% |
-0.7% |
66.9% |
| SENSEX | -1.1% |
-3.6% |
-5.3% |
You may also like the below Video Courses